Patients were randomly allocated to receive TXA (loading dose of 1.0 gram over ... Each treatment pack contained unlabelled vials of either drug or placebo. Although drug and placebo vials ...
This study reports results from a prospective, randomized, double-blind trial. Use of IV tranexamic acid did not significantly improve visual field clarity during hip arthroscopy vs. use of placebo.
Tranexamic acid, an antifibrinolytic agent used to control ... Actions such as color-coding labels and differentiating vial sizes have mitigated some risks, but the potential for cap color ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results